Skip to main content
. 2014 Jan 13;43(3):20130016. doi: 10.1259/dmfr.20130016

Table 3.

Group-wise distribution of clinically involved oral sites in Groups I–IV

Sites Group I Group II Group III Group IV
1–2 1 0 0 0
3–4 4 0 2 0
5–6 1 3 1 0
7–8 2 6 6 4
9–10 2 1 1 3
>10 0 0 0 3